English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective   To investigate the effect of supplemental dexmedetomidine in interventional embolism on cerebral oxygen metabolism in patients with intracranial aneurysms.Methods   Ninety patients who underwent interventional embolism of intracranial aneurysms were equally divided into Group A and Group B. In Group A, dexmedetomidine was injected intravenously 10 minutes before inducing anesthesia, with a loading dose of 0.6 µg/kg followed by 0.4 µg/kg/hour. Group B received the same amount of normal saline by the same injection method. Heart rate (HR), mean arterial pressure (MAP), arterial–jugular venous oxygen difference [D(a-jv) (O 2 )], cerebral oxygen extraction [CE (O 2 )], and intraoperative propofol use were recorded before inducing anesthesia (T 0 ) and at five time points thereafter.Results   The amount of propofol in Group A was lower vs Group B. At all five time points after T 0 , HR, MAP, D(a-jv) (O 2 ), and CE (O 2 ) in Group A were significantly lower vs Group B, with significant differences for jugular venous oxygen saturation (S jv O 2 ) and the oxygen content of the internal jugular vein (C jv O 2 ) between the groups.Conclusion   Dexmedetomidine resulted in less intraoperative propofol, lower D(a-jv) (O 2 ) and CE (O 2 ), and improved cerebral oxygen metabolism.

Effect of supplemental dexmedetomidine in interventional embolism on cerebral oxygen metabolism in patients with intracranial aneurysms